Market revenue in 2023 | USD 175.5 million |
Market revenue in 2030 | USD 366.5 million |
Growth rate | 11.1% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 56.87% in 2023. Horizon Databook has segmented the Asia Pacific deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific deep brain stimulation devices market is anticipated to exhibit lucrative growth during the forecast period. Rising prevalence of neurodegenerative and psychiatric disorders coupled with unmet need for effective & long-term treatment solutions is expected to present significant growth opportunities for deep brain stimulation devices in this region.
Moreover, high R&D investments by global market players owing to their low-cost structure are among the key drivers of the market in Asia Pacific region. Rising awareness about neurological disease treatment options and improvements in clinical development framework of emerging economies are expected to drive the market growth.
Furthermore, establishment of organizations such as the Asia-Pacific Centre for Neuromodulation (APCN), which is founded for conducting research and promoting awareness about associated benefits of deep brain stimulation, is anticipated to boost market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account